August 2011 Research News
Is Switching Hormonal Therapies Better Than Taking Only One?
August 23, 2011
Research suggests that taking tamoxifen for 2 to 3 years and then switching to an aromatase inhibitor might be better than taking only tamoxifen or only an aromatase inhibitor for 5 years to reduce recurrence risk and improve overall survival. Read more...
Older Women with Existing Heart Problems, Diabetes Have Higher Risk of Heart Function Problems with Herceptin
August 10, 2011
A small study suggests that women 70 and older who have existing heart problems or diabetes are more likely to develop heart problems if treated with Herceptin for breast cancer. Read more...
Soy Supplement Doesn’t East Hot Flashes or Prevent Bone Loss
August 8, 2011
Menopausal women who took isoflavone tablets every day for 2 years didn't get any relief from hot flashes; the isoflavone tablets also didn't prevent bone loss. Read more...
Women with Dense Breasts Have Higher Risk of More Aggressive Cancer
August 1, 2011
Research suggests that women with dense breasts are more likely to be diagnosed with breast cancer and the breast cancer is likely to be more aggressive. Read more...
Can we help guide you?
Create a profile for better recommendations
-
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....
-
Breast Cancer Stages
The stage of a breast cancer is determined by the cancer’s characteristics, such as how large it...
-
Cancer Survivors Overestimate Quality of Their Diets
Most people who have been diagnosed with cancer think they eat a healthy diet, but a study found...
